By Amy Norton HealthDay Reporter THURSDAY, Aug. 4, 2022 (HealthDay News) — Researchers are reporting early but encouraging findings on a potential new way to prevent malaria — an old foe that still ranks as a major killer worldwide. In a small trial of healthy volunteers, U.S. government researchers found that a lab-engineered antibody protected … Read more
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses. The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study. Monoclonal antibodies are laboratory-made proteins that mimic the immune … Read more
Lanson Jones, Houston. Howard Huang, MD, pulmonologist, Houston Methodist Hospital. Amesh Adalja, MD, emerging infectious diseases specialist, Johns Hopkins University Center for Health Security. Terry Scoggin, CEO, Titus Regional Medical Center, Mount Pleasant, TX. Frederick Thurmond, MD, hospitalist, Titus Regional Medical Center. Seth Thurman, Mount Pleasant, TX. Whitehouse.gov: “Remarks by President Biden … Read more
Infectious Diseases Society of America: “Monoclonal Antibodies.” The New England Journal of Medicine: “Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.” William Fales, MD, medical director, Michigan Department of Health and Human Services, Division of EMS and Trauma. Lindsay Petty, MD, infectious disease doctor, University of Michigan. Eli Lilly: “Emergency Use Authorization (EUA) for the … Read more
April 13, 2021 – People living with someone who has COVID-19 appear to get powerful protection against infection when they are given Regeneron’s antibody cocktail, a new study shows. The findings suggest that beyond preventing the worst outcomes for coronavirus infection when given early enough, the cocktail could also prevent people from getting sick … Read more
Early study data shows that the Regeneron therapy is safe and has few side effects, according to CNN. Human clinical trials began in June, and late-stage trials started in July. Some scientists are awaiting more data and a peer review to decide how well the drug works. “I would withhold judgment on this until … Read more